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Abstract 
Leaders in the profession of pharmacy have articulated a vision of pharmacists as providers of patient-centered care (PCC) services 
and the Doctor of Pharmacy was established as the required practice degree to achieve this vision. Pharmacist-provided PCC services 
have been shown to reduce medication costs and improve patient compliance with therapies. While community pharmacists are 
capable of, and are ideally placed for, providing PCC services, in fact they devote most of their time to prescription dispensing rather 
than direct patient care. As professionals, community pharmacists are charged with protecting society by providing expert services to 
help consumers manage risks associated with drug therapies. Historically pharmacists fulfilled this responsibility by accurately 
dispensing prescription medications, verifying doses, and allergy checking. This limited view of pharmacy practice is insufficient in 
light of the modern view of pharmacists as providers of PCC. The consumers’ view of community pharmacy as a profession represents 
a barrier to transforming the basis of community pharmacy from product distribution to providing PCC services. Community 
pharmacists are conferred with social authority to dictate the manner in which their professional services are provided. Pharmacists 
can therefore facilitate the transition to PCC as the primary function of community pharmacy by exercising their social authority to 
engage consumers in their roles in the new patient-pharmacist relationship. Each pharmacist must decide to provide PCC services. 
Suggestions for initiating PCC services in community pharmacy are offered. 
 
Introduction 
For more than fifty years, a debate whether the fields of 
pharmacy constitute a profession has appeared in the 
pharmacy literature.
1-8
  This debate is currently sustained by 
continuing efforts to transform the basis of community 
pharmacy practice from product distribution to patient-
centered care (PCC) services. Pharmacy leaders have 
articulated a vision of pharmacists as providers of PCC 
services and established a Doctor of Pharmacy as the 
required practice degree to implement this vision
9
. 
PCC is defined “an approach that adopts *the+ perspective of 
patients–what matters to them, what affects them either 
positively or negatively, and their experience of illness,” and 
more specifically as “providing care that is respectful of and 
responsive to individual patient preferences, needs, and 
values and ensuring that patient values guide all clinical 
decisions.”
10,11
 Pharmaceutical care, defined as “the 
responsible provision of drug therapy for the purpose of 
achieving definite outcomes that improve a patient’s quality  
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of life,” is an expression of PCC in the context of pharmacy 
services.
12
 Pharmacist-provided PCC services generally 
include collecting, maintaining, and evaluating patient-
specific health information and the direct consultation with 
patients and their other healthcare providers to implement, 
monitor, and revise care plans according to patient 
outcomes.
13-15
  These functions are consistent with the IOM 
recommendations to empower pharmacists to participate in 
collaborative drug therapy management services and to 
empower patients in their own healthcare.
11
 Despite some 
limitations in study design, the Asheville Project and the 
Diabetes Ten City Challenge have demonstrated the benefits 
of pharmacist-provided PCC in decreasing healthcare costs 
and improving patient outcomes.
16,17
 
Most pharmacists practice in a community setting. 
Consumers received more than 3.6 billion prescriptions from 
community pharmacies in 2009.
18,19
 While community 
pharmacists are capable of, and are ideally placed for, 
providing PCC services, in fact they devote most of their time 
to prescription dispensing rather than direct patient care.
18
 A 
consortium of pharmacy organizations responded to this 
challenge with Project Destiny, a program to develop a 
patient-centered practice model for community pharmacy. 
The Project Destiny Business Plan contains analyses of the 
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opportunities and barriers for the transition of community 
pharmacists into providers of PCC services. Any realistic 
practice model must be economically viable, and the 
document is appropriately focused on securing 
reimbursement for pharmacists' professional services.
20
 
Barriers to implementing a new professional practice model 
are not all economic, however. Society must participate in 
altering the roles of both pharmacist and medication 
consumer before patient care can become the primary role of 
community pharmacists. Further significant progress toward 
professional transformation requires that community 
pharmacy engage its necessary partner: the patient. 
The transition of pharmacists to providers of PCC services 
requires a different patient-pharmacist relationship than that 
maintained by the current community pharmacy model. 
Because this new relationship demands new behaviors and 
modes of thinking by both pharmacists and patients, the 
desired transition represents a culture change. Ironically, the 
most obvious barrier to the transition, i.e. the pharmacist’s 
responsibility for prescription dispensing, is an essential tool 
to facilitate the transition. Community pharmacists are 
conferred with social authority to dictate the manner in 
which their professional services are provided. Pharmacists 
can therefore facilitate the desired culture change by 
exercising their social authority over pharmacy services to 
engage consumers in their roles in the new patient-
pharmacist relationship.  
The Evolution of Community Pharmacy 
The generally accepted model of pharmacist-provided PCC is 
based on clinical pharmacy services as practiced in large 
hospitals and clinic settings.
13-15,20
 Hospital pharmacists 
initiated clinical pharmacy services (drug information, 
pharmacokinetic dosing, pharmacists serving on patient care 
teams) in the 1960’s to address unmet needs in the 
medication use process.
21
 These services expanded in large 
hospitals throughout the 1970s and 1980’s. Pharmacist-
intensive services were facilitated by pharmacy departments’ 
use of trained technicians as well as prepackaged and pre-
labeled unit-dose medications in the dispensing process to 
increase pharmacists’ availability for direct patient care. The 
evidence that clinical pharmacy services improved patient 
outcomes and reduced healthcare costs formed the basis for 
the Hepler and Strand model of pharmaceutical care.
12
 
Pharmacy school curricula were revised to include training in 
patient-centered care and the patient-focused PharmD was 
eventually adopted as the required practice degree. 
In contrast to the recent, purposeful establishment of clinical 
pharmacy practice, modern community pharmacy is the 
result of a century-long evolutionary path. Pharmacy at the 
turn of the 20th Century was equal parts skilled craft and 
retail business. Most prescriptions were compounded. 
Pharmacists also sold patent medicines and various tonics as 
part of their sideline businesses to supplement prescription 
sales. The public health movement during the early 1900’s 
provided a stimulus for initializing the professionalization of 
pharmacy. Pharmacists began to apply their knowledge on 
health matters to “inform parents and victims of the 
unsuspected ravages of diseases which in their ignorance 
they believe to be of little importance.”
22
  
Counter prescribing, the practice of a pharmacist suggesting 
and selling medications to treat a patient without a 
physician’s order, was common in 1900. Pharmacists were 
essentially diagnosing, prescribing, and dispensing within the 
pharmacy. Physicians were wary of counter prescribing as an 
intrusion into their control over therapeutic decision-making. 
Pressure from physicians and like-minded pharmacists 
brought an end to counter prescribing by 1940.
23
 Pharmacists 
generally accepted responsibility for preparing and 
distributing medications ordered by physicians; thereby, in a 
sense, assuming a subservient professional status in the 
healthcare system. They embraced the role of drug 
compounding expert and resource for physicians.  
Mass production and the introduction of new drugs in the 
post-WWII years caused a rapid increase in the dispensing of 
manufactured products. By the mid-1950’s, the declining 
importance of compounding in the community drug store 
precipitated a search for new roles for pharmacists in the 
healthcare system. Eugene White, Robert Swain, Donald 
Francke, and other leaders in the profession saw an 
opportunity to utilize pharmacists as drug experts who could 
educate physicians on the growing number of drugs being 
introduced to the market and ensure the appropriate use of 
drugs by consumers.
3,8,24,25
 Educational requirements 
expanded over time to better prepare pharmacy graduates 
for their changing roles. Some community pharmacists 
attempted to formalize patient counseling as a professional 
service with an attendant professional fee as early as 1957.
7
 
Although unsuccessful, this initiative foretold changes within 
the community pharmacy structure to address unmet needs 
in medication use.
26
 
The 1952 Durham-Humphrey amendment to the 1938 
Federal Food, Drug, and Cosmetic Act further defined the 
future of community pharmacy by establishing prescription 
and non-prescription drugs classes.
27
 Under this law, 
prescription drugs were only to be sold to consumers by a 
licensed pharmacist upon order from a licensed physician. 
The community pharmacist was thus defined as custodian of 
drug products and charged primarily with protecting the 
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safety of the consumer by regulating distribution of these 
drug products. Meanwhile, the APhA Code of Ethics of 1952 
prohibited pharmacists from discussing drug therapies with 
patients.
28
 Community pharmacists worked pursuant to a 
physician’s order on behalf of a patient, but not directly with 
the patient. American consumer culture evolved to embrace 
drug products as commodities and pharmacists as highly 
trained purveyors of medicines. Therefore, while the number 
of prescription medications was rapidly expanding, American 
consumers were being socialized to expect their pharmacist 
to dispense medications but to not become involved in the 
medication use process, nor in their overall healthcare. 
Pharmacists’ responsibility for dispensing, which remains the 
cornerstone of community pharmacy today, represents both 
a barrier and an opportunity for community pharmacists as 
they transition to providers of PCC services. 
Community Pharmacists as Professionals 
Professional and professionalism have been defined in 
various ways. In a recent review of professionalism, 
Wilkinson, Wade and Knock identify five primary elements 
that are present in various definitions and interpretations of 
medical professionalism: 
i. Adherence to ethical practice principles 
ii. Effective interactions with patients and 
with people who are important to 
those patients 
iii. Effective interactions with other people 
working within the health system 
iv. Reliability 
v. Commitment to autonomous 
maintenance and continuous 
improvement of competence
29
 
Historically, sociologists found professions as self-policing, i.e. 
establishing practitioner oversight to ensure that these 
elements are maintained and consistently offered to the 
external community.
30,31
 However, most of these functions 
have been assumed by “professional boards of certification” 
operating in individual states.
32
 Characteristics such as those 
proposed by Wilkinson, et. al are useful to understand 
behaviors expected of a professional, but they do not 
illuminate the nature of a patient-pharmacist relationship, 
which we believe is essential to pharmacist’s professional 
roles. Professionalism for community pharmacists involves 
more than the acquisition of knowledge and skills to conform 
to a checklist of procedures.   
Pharmacists practice within the confines of well-defined 
social relationships with physicians and medication 
consumers, so professionalism must be considered in the 
context of this social structure. In this light, a more relevant 
view of professionalism is provided by Evetts.
33
 Rather than 
defining characteristics or motivational aspects of 
professionalism, Evetts asserts that professional authority 
derives from a social structure established in collaboration 
with society. Professions are established, at least in part, to 
assist society in dealing with risks.
33
 Evetts specifically 
identifies pharmacy’s claim to professionalism as the societal 
grant of control over a specialized area of “knowledge-
work.”
33,34
 The founding of a profession represents a quid pro 
quo. Society grants control over a specified area of 
knowledge-work because its members understand and 
believe in the necessity of the professionals’ work and 
because laypersons are unable to do the work for 
themselves. In exchange for the grant of control over 
pharmacy-based knowledge-work, a professional pharmacist 
is obligated to use his/her expert knowledge to assist patients 
in managing the risks associated with drug therapy.  
As part of the grant of control over specific knowledge-work, 
professions are conferred authority by society to determine 
the manner in which professional services are provided. 
Historically, the pharmacy profession’s primary societal 
charge has been to protect consumers by the purposeful 
transfer of medication custody. To this is added a value that is 
based upon the expression of professional knowledge-work, 
and the power to add that value lies in professionalism. Social 
authority for pharmacists is the power to add value to 
dispensed medications. Pharmacists, therefore, have social 
authority to impose reasonable conditions on the transfer of 
prescription medications to a consumer in order to best 
protect the consumer’s health.  
The Evetts interpretation of professionalism clarifies the 
challenges facing the pharmacy profession as it strives to 
implement PCC as pharmacists’ primary function. Community 
pharmacy differs from other healthcare professions, including 
hospital-based clinical pharmacy, in that consumers do not 
view community pharmacists primarily as providers of PCC 
services. Rather, the consumer enters a community pharmacy 
as part of his/her responsibility in the patient-physician 
relationship, i.e. the physician orders the patient to acquire 
prescription medication from a pharmacist and to use the 
medication as instructed to improve their health. Community 
pharmacy services are commoditized in terms of the 
consumer’s out of pocket expense (e.g. $4 generic 
prescriptions, free antibiotics, cash incentives for transferring 
prescriptions from a different pharmacy), speed with which 
medications are dispensed, and convenience to the consumer 
(e.g. pharmacies as department stores, drive-through 
windows, 24-hour accessibility). Consumers view the 
community pharmacy as a retail outlet for drug products, not 
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as a venue for receiving professional PCC services. 
Community pharmacy requires revision of the societal grant 
defining responsibilities for pharmacy-based knowledge-work 
to emphasize pharmacist-delivered PCC services for the 
purpose of maximizing patient health. In more practical 
terms, consumers of community pharmacy services must 
make the transition from customer to patient.  
A consumer becomes a patient via acceptance of a sick role. 
The sick role, formalized by Talcott Parsons in 1951 and 
further elaborated by Parsons and others, legitimizes an ill 
person in the healthcare social system.
35-37
Within this system, 
a patient presents him/herself to healthcare professionals as 
“wanting to get well” and submits to their social authority to 
obtain counsel, assess risks, and manage specific products to 
achieve wellness. The professional has the responsibility to 
be accessible to the patient and to apply his/her specialized 
expertise to achieve the optimal therapeutic outcomes for 
the patient. When the sick role and professional roles come 
together a professional bond is formed.  
This conception of the sick role is appropriate for acute illness 
(e.g. minor infection) where the patient is expected to return 
to health from the current illness. A model of patienthood, a 
staple of medical sociology, is better applied to patients with 
chronic illness (e.g. hypertension or diabetes).
38-40
 In both 
structures, an ill person is labeled as a patient by a physician. 
Patient-centeredness requires sensitivity to the effects of 
diagnoses on patients’ self-image. A person labeled as patient 
for an acute illness can accommodate the label within their 
self-concept because health, or “normalcy,” will soon return. 
On the other hand, a person labeled as patient for chronic 
illness must reorganize his/her self-concept to accommodate 
a new social definition of “normal.” Pharmacists initiating PCC 
may find it easier to approach patients with an acute label 
than patients with a chronic illness label. Although the latter 
may, indeed, benefit more from pharmacy services.
41
 
The relative balance of social authority determines the course 
of any professional interaction. The physician holds the 
greatest authority in the US healthcare system. Patient-
centered healthcare services (e.g. diagnostic testing, 
treatment by other healthcare professionals) are generally 
only made available to the patient pursuant to a physician’s 
order, i.e. specific instructions to an allied health professional 
to provide services on the patient’s behalf. While a patient 
has significant autonomy to select the providers of these 
services, consumers must submit to the authority of a 
physician in the patient-physician relationship to enter the 
healthcare system. A physician’s order is required for the 
patient to receive services. The physician’s order binds the 
patient to the sick role.  
Hospital- and clinic-based pharmacists have significant social 
authority over patients as a result of the physician-patient 
relationship. The success of pharmacist-provided PCC in these 
settings is largely due to the physicians’ delegation of 
authority to pharmacists for the purpose of providing drug-
related patient care. This delegation is formalized in hospital 
organizational policies and collaborative practice agreements 
and is binding on the sick patient. A patient submits to the 
social authority of both their physician and pharmacist as part 
of the sick role. 
The sick role does not extend the physician’s social authority 
to the community pharmacist to the same degree, however. 
A prescription in the hand of a non-hospitalized patient is not 
interpreted as an order for the pharmacist and patient to 
enter into a professional PCC process. Consumers generally 
do not consider themselves patients in the community 
pharmacy, nor do they view filling prescriptions as a 
professional interaction akin to visiting a physician. Rather, 
the prescription is an order to transfer medications from the 
custody of the pharmacist to the consumer. Knowledge-work, 
in the consumers’ view of community pharmacy as a 
profession, is associated with dose verification, accurate 
dispensing, allergy checking, etc. Consumers possess a similar 
level of social authority to that of community pharmacists in 
that they select a pharmacy to patronize (within insurance 
plan limits) and control the extent of their interaction with 
pharmacists. They may avoid personal contact with 
pharmacists and receive their medications via mail order or a 
drive-through window. Non-hospitalized consumers are thus 
patients to their physicians and customers to their 
pharmacists. Consequently, the pharmacy profession must 
accept the responsibility to facilitate the consumer’s 
transformation from customer to patient. 
Redefining the Patient-Pharmacist Relationship 
Stimulating a professional relationship between pharmacist 
and patient begins at the community level because 
consumers must perceive pharmacists as necessary experts 
within the healthcare system. Pharmacists may achieve 
recognition in the community by participating in public health 
efforts.
42
 The American Society of Health-System Pharmacists 
formalized a policy, initially stated in 1980 by the American 
Public Health Association, that pharmacists have 
responsibilities to actively participate and promote public 
health efforts.
43,44
 These responsibilities include specific 
population-based care, health education, development of 
public health policy, and research and training specific to 
public health goals of disease prevention and the health 
needs of the national population. Furthermore, Smith and 
Olin believe pharmacists should advocate healthy lifestyles at 
the community level.
45
 They take formalized pharmacy 
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education to task for not preparing graduate pharmacists to 
address the health risks represented by their customers’ poor 
diet, sedentary lifestyle, obesity, tobacco consumption and 
excessive alcohol use.  
Public health efforts will help society understand, value, and 
desire pharmacists as providers of PCC services. Without the 
awareness generated by pharmacy’s public health mission, 
many consumers will not know what to expect in terms of 
pharmacist-provided PCC services and choose to remain 
customers when they could be better served by acting as 
patients.
46-50
 Renberg, Lindblad, and Tully reported that 
patients they interviewed did not “spontaneously” speak of 
the pharmaceutical care services they had already received, 
and did so only after prompting.
51
 Worley et al. similarly 
found that patients were not aware of the roles pharmacists 
expected of them in PCC.
52
 Educating consumers about their 
roles in the patient-pharmacist relationship is therefore 
another important public health goal. Consumer awareness 
of community pharmacists’ healthcare expertise increases 
opportunities to engage patients in PCC.  
The pharmacist’s assertion of professionalism must be 
demonstrated by personal accountability to individual 
patients who present themselves for PCC services. The 
existing community pharmacy practice model contains the 
essential elements for effective delivery of PCC services: 
consumers and pharmacists brought together in a 
professional environment by a physician’s order for transfer 
of prescription medications. The centerpiece of an effective 
PCC-oriented care model is the professional relationship 
between patients bound to the sick role and a community 
pharmacist committed to “providing patient care that 
ensures optimal mediation therapy outcomes.”
9
 A patient’s 
need for prescription medications stimulates the professional 
relationship, medications are accurately dispensed according 
to best practices, and the patient and pharmacist engage in 
PCC processes appropriate to the individual patient’s needs. 
This can be achieved by reassembling the components of the 
existing community pharmacy practice model for the purpose 
of supporting the pharmacist as a provider of professional 
PCC services. 
The specific procedures involved in the pharmacist-provided 
PCC are common knowledge within the pharmacy 
profession.
13,15
 The pharmacist must establish a relationship 
with each patient based on mutual trust and commitment to 
the patient’s well being. The pharmacist must document 
health and medication histories, current medications, etc. to 
allow an objective assessment of the patient’s health needs. 
Community pharmacists typically do not have access to a 
patient’s medical record, so the patient’s physician is 
contacted for information the patient cannot provide (clinical 
lab data, specific diagnoses, etc.). The pharmacist solicits 
feedback from the patient and physician (as appropriate) 
regarding the patient’s therapeutic progress, side effects 
experienced, and compliance with therapy, and recommends 
alterations to the therapeutic regimen as appropriate. The 
continuous assessment of patient progress is integral to 
providing PCC. In addition to providing PCC services, the 
pharmacist is responsible for ensuring that prescription 
medications are dispensed accurately and in a timely fashion. 
The patient must actively participate in his/her own care 
beginning with a commitment of time to the process. With 
the pharmacist’s guidance, the patient provides relevant 
health information, articulates his/her personal goals for drug 
therapy and preferences regarding therapeutic options, and 
provides frank and complete feedback allowing the 
pharmacist to monitor and evaluate efficacy of the drug 
therapy. The patient is responsible for adherence to the 
treatment plan prepared by the pharmacist for the specific 
patient.  
Continuous monitoring of patient responses to therapy 
contrasts basic prescription counseling from the more 
intensive PCC process. Pharmacists must apply effective 
communication skills and probe patients’ attitudes toward 
the medication use, subjective perceptions of health or 
illness, fears and concerns about therapy, etc. Such 
conversation allows pharmacists to apply professional 
judgment to promote optimal outcomes for their patients 
and to genuinely integrate the patient in the PCC process. 
Some situations may warrant the pharmacist’s calling a 
patient at home to monitor drug therapies between patient 
visits to the pharmacy. Pharmacists’ routine monitoring of 
patients, rather than medications, promotes closer 
professional relationships and active engagement by patients 
in the PCC process. 
The pharmacy environment and workflow processes must be 
designed to facilitate PCC services. Mutual trust is a 
cornerstone of the patient-pharmacist relationship. A private 
and comfortable space in the pharmacy is necessary to 
promote effective patient-pharmacist interactions. The 
pharmacy must employ appropriately trained support staff 
(technicians, cashiers) to accept and reliably perform the non-
professional aspects of pharmacy operations while the 
pharmacist is engaged in professional activities. The 
pharmacy must have a suitable patient record system to 
support the pharmacist’s PCC mission. 
There are costs associated with the patient status, including 
investments in time and intellect in the PCC process, 
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increased dependence on healthcare professionals, and self-
image as an un-well person (even considering modern ideas 
about wellness). Therefore, pharmacists must clearly 
demonstrate the benefits of PCC services to the patient. The 
economic and therapeutic benefits of pharmacist-provided 
PCC services have been shown in large-scale studies.
16,17
 
Experience from a variety of community pharmacies (chain 
and independent) and ambulatory clinics indicates that 
patients tend to be more adherent to and satisfied with their 
drug therapies when they receive PCC services from their 
community pharmacist.
17,53,54
 Pharmacists can also discuss 
the impact of each patient’s engagement in PCC on their own 
therapeutic progress. Patient empowerment, the acquisition 
of sufficient knowledge and accurate self-awareness to make 
successful choices to attain health-related goals, frequently is 
understood as a prerequisite to patients entering a 
professional relationship with a healthcare provider.
51,55
 
Patient empowerment may also develop as a result of the 
professional relationship.
53
 
Pharmacists benefit from engaging patients in PCC. 
Pharmacists who provide PCC services enjoy the admiration 
of the patients and collaboration as colleagues with 
physicians who valued their collaboration.
53,54,56
 Patient care 
promotes pharmacist job satisfaction by instilling a sense of 
professional autonomy and empowerment.
57,58
 
Employers are responsible for implementing workflows and 
creating a culture where patient care is the organization’s 
highest priority. While we cannot comment on 
reimbursement strategies, offering pharmacist-provided 
patient care services can help a pharmacy (or pharmacy 
chain) differentiate itself from the competition and 
contribute to the strength of a brand. Patient satisfaction 
with professional services can increase customer loyalty to 
the pharmacy. Improved patient adherence with drug 
therapy drives prescription refills and extends to filling new 
prescriptions. Allowing pharmacists to provide PCC services 
makes more efficient use of the pharmacy resources and 
improves opportunities for pharmacists to interact with 
physicians and other third parties as necessary to better 
serve patients. Pharmacy costs are reduced as pharmacists 
experience greater job satisfaction and decreased job 
turnover associated with providing patient care.
57,59
  
Suggestions for implementation 
Pharmacists transform customers into patients by creating 
the cultural expectation that PCC services are an integral part 
of receiving prescription medications. Community 
pharmacists’ social authority over prescription dispensing 
provides the means to create this cultural expectation. The 
“Rx only” designation means that consumers may only use 
prescription medications under the supervision of qualified 
healthcare professionals. The pharmacy profession is charged 
with the responsibility to protect society from risks associated 
with drug therapy by providing expert services that 
laypersons are not capable of providing for themselves. It is 
therefore a pharmacist’s ethical duty to dispense prescription 
medications only to patients who have received appropriate 
PCC services. Social authority is an essential tool to convince 
patients that pharmacist-provided PCC services are integral to 
the medication use process. The responsibility for 
prescription dispensing, the historical centerpiece of 
community pharmacy practice, therefore affords community 
pharmacists the opportunity to elevate their practice to that 
of a patient-centric, caring profession. 
Implementation of the PCC services in the community 
pharmacy thus begins with a proactive choice by a 
pharmacist to fulfill his/her professional obligations to ensure 
their patients’ optimal medication therapy outcomes. A 
pharmacist committed to this goal is essential for the delivery 
of PCC services. Recent evidence suggests that the majority of 
community pharmacists prefer to spend their time in 
dispensing rather than patient care.
18,60
 This issue has been 
addressed by the profession via the mandatory PharmD 
degree, as recent graduates are more inclined to providing 
patient care than pharmacists who have been in practice for 
many years.
18,60
  
A pharmacist’s public health mission can begin with in-store 
signage and advertising that emphasizes the professional 
services available and educates consumers on pharmacists’ 
personal accessibility as healthcare experts, e.g. “… large 
enough to meet your healthcare needs and small enough to 
know your name.” These approaches can also be used to 
initiate discussions about specific public health and wellness 
issues. Patients may be recruited into professional interaction 
regarding smoking cessation, maintaining a healthy body 
weight, the societal need to secure drugs of abuse, etc. 
Pharmacy websites and social media profiles dedicated to 
medication matters can increase the impact of public health 
efforts. Ending the sale of tobacco and alcohol in pharmacies 
would certainly increase the credibility of these messages. 
A committed pharmacist can begin providing PCC services by 
taking the initiative to engage patients in professional 
discussion rather than speaking only with those who request 
it. One simple approach to accomplish this goal is for the 
pharmacist to personally convey filled prescriptions to the 
consumer.  Customers are encouraged to make the transition 
to patients when their pharmacist endorses the value of PCC 
services by proactively initiating professional interaction with 
them. There is no more visible demonstration of the 
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pharmacist’s accessibility than presenting medications to the 
patient and providing PCC services the patient needs to best 
benefit from the medications. In contrast, assigning a cashier 
to ask the consumer “Do you have any questions for the 
pharmacist?” is an undeniable statement that the pharmacist 
has higher priorities than providing PCC services.  
Patient feedback, the primary mode by which community 
pharmacists monitor drug therapy, is most easily solicited 
when patients return to the pharmacy for medication refills. 
Speaking with every patient affords the opportunity for the 
pharmacist to regularly gather information from patients, 
update patients’ health and medication profiles, monitor 
adherence with therapies, document other medications being 
used, etc. The future availability of universal electronic 
patient records will facilitate PCC services by providing the 
pharmacist access to current patient health data. Existing 
technology such as “refill reminder” telephone or email 
systems support the pharmacist’s PCC mission by promotion 
a patient’s medication adherence between pharmacy visits. 
Some pharmacies offer medication therapy management 
(MTM) services on defined “clinic” schedules where a 
pharmacist is available to provide in-depth education on 
particular disease states (asthma, smoking cessation, 
diabetes, etc.) and actively engage the patient as a 
participant in their own care.
61
 MTM clinics have several 
benefits for a pharmacist committed to providing PCC 
services. Patients who participate surely benefit from 
professional pharmacy services in improved therapeutic 
outcomes. Those patients who participate in MTM clinics are 
trained in the behaviors expected of a patient in the 
pharmacy, thereby contributing to the desired culture change 
for community pharmacy. Pharmacists who provide MTM 
services build professional relationships with their patients 
and continually hone their patient care skills. Perhaps equally 
important for the profession, every consumer who enters the 
pharmacy is exposed to professional advertising regarding 
the clinic offering and is introduced to the concept of 
community pharmacists as providers of PCC. A sustained 
MTM clinic program is not sufficient, however, to transform 
community pharmacy into a patient-centered caring 
profession. A pharmacist’s ethical duty is to provide 
appropriate professional services to all patients, not only 
those who voluntary participate in MTM clinics. A pharmacist 
can begin by offering MTM clinics then use his/her 
experience as the basis for incorporating PCC into the routine 
pharmacy workflow.  
A private space for consultation between the patient and 
pharmacist is essential to protect patient privacy and 
confidentiality and to underscore the importance of PCC 
services. The best-intentioned pharmacist will find it 
impossible to engage patients in PCC if there is no assurance 
of patient privacy. A public counter directly adjacent to a cash 
register is not a conducive environment. Some stores offer 
the concession of segregating a continuous counter space 
with vertical partitions in an attempt to create the illusion of 
privacy for patients. While these structures are a small step in 
the right direction, patients may still feel reluctant to share 
personal information in such an environment. The physical 
layout of the pharmacy should be designed to provide 
maximum privacy for the professional interaction. 
The most important factor in implementing PCC services is 
the proactive choice by a pharmacist to engage patients and 
take responsibility for their medication therapy outcomes. A 
motivated pharmacist will have no difficulty finding advice on 
how to implement specific PCC services. Pharmacy journals 
regularly publish scholarly papers, articles on innovations and 
experiences in pharmacy practice, and continuing education 
programs intended to assist pharmacists in developing and 
enhancing their PCC services. Professional pharmacy 
organizations’ websites maintain links to practice-related 
resources for pharmacists. Pharmacists can subscribe to 
weekly email digests of recent developments in practice. 
Community pharmacists may perceive barriers in their 
workplaces that limit their professional accessibility to 
patients and that may preclude their offering of PCC services. 
Overwhelming prescription workload is commonly mentioned 
as preventing pharmacists from interacting with patients. The 
solution to this problem is to stop misapplying the 
pharmacist’s time on filling and labeling prescription vials or 
communicating with insurance company representatives 
regarding rejected claims. Pharmacists can expand their time 
for providing professional services by assigning these tasks to 
trained technicians and by employing technology in the 
dispensing process. Support staff perform these duties well 
for other primary care providers and insurance companies, 
and technicians can perform them for community 
pharmacies. “Tech check tech” programs, where certified 
technicians check the work of other technicians, may be 
implemented in community pharmacy.
62
 The professional 
pharmacist’s need for effective support staff strongly 
supports the recent call for uniform national credentialing 
standards for pharmacy technicians.
63
 Large pharmacies may 
be able to cross-train “front-end” clerks to assist in the 
pharmacy department at times of peak demand. 
Pharmacists can begin providing PCC services using a phased 
approach: patients with the greatest perceived need (e.g. 
acute versus chronic disease, severity of disease state, 
number of concurrent medications, history of non-
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adherence) may be engaged first, followed by those of 
progressively lower priority until the PCC service is routine for 
all patients. The “levels of care” concept can be applied in 
therapeutic collaboration with individual patients to 
determine the extent of PCC services required.
64
 Some 
patients will require extensive care services over a sustained 
period of time, while others will require only basic education 
limited to an acute illness. 
The patient’s physician may be required periodically to 
provide input into the PCC process. Initially, some physicians 
may be reluctant to engage in this aspect of their patients’ 
care. While it is routine for pharmacists to collaborate with 
physicians in hospital and clinic settings, community 
pharmacists typically do not share this level of collegiality 
with physicians. Patients can lobby their physicians on their 
own behalf to facilitate data sharing and therapeutic 
decision-making with their pharmacist. Engaging patients in 
interactions with their physicians may also raise the 
physicians’ awareness of the community pharmacist-provided 
PCC services. Pharmacists may reinforce their PCC roles in 
regular interactions with physicians. While some physicians 
may resist pharmacist authority, research has revealed that a 
welcome collaboration with many physicians may occur in 
the context of pharmacist-provided PCC services.
53
 
Employee pharmacists may need to lobby management for 
authorization to redesign workflows for the purpose of 
offering PCC services. National pharmacy chains have opened 
health clinics staffed by nurse practitioners and physicians 
assistants adjacent to their pharmacy departments.
65,66
 
Pharmacists employed by these pharmacies may find 
opportunities to integrate PCC services with the health clinic 
services. Pharmacists can track the costs associated with each 
incremental service offering as well as their patients’ 
outcomes, adherence to therapy, prescription refill rates, the 
number of new and returning patients, etc. to establish the 
value of their own services. These data can guide workflow 
adjustments that further support enhanced PCC services. 
Management, in turn, can use the data to propose 
reasonable reimbursement for their pharmacists’ 
professional pharmacy services. The quantification of services 
can also be used in public service announcements and in-
store signage, e.g. “Our pharmacist can help you reduce your 
asthma attacks while lowering your medication costs.” 
Conclusion 
Pharmacists, as professionals, are charged by society with 
helping consumers manage the risks associated with drug 
therapies. Each pharmacist must choose to fulfill his/her 
professional obligation by providing appropriate PCC services. 
Community pharmacists who choose to provide PCC must 
accept the responsibility to transform their customers into 
patients. Pharmacists are conferred with social authority to 
accomplish this mission. Community pharmacists, specifically, 
have the authority to impose appropriate PCC services as a 
condition of dispensing prescription medications to their 
patients. PCC services may be provided within the context of 
the existing community pharmacy practice model by 
redesigning workflow processes to maximize time available 
for professional patient-pharmacist interaction. The proactive 
choice by a pharmacist to provide PCC services is the critical 
first step in achieving PCC as the primary function of the 
community pharmacy practice. 
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